Koninklijke Philips | PHG - Selling And Administration Expenses


Koninklijke Philips reported EUR1.18B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.6B 330M Jun/2026
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Boston Scientific USD 1.8B 22M Jun/2026
Danaher USD 2.07B 212M Jun/2026
Demant DKK 6.09B 135M Dec/2025
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Fresenius EUR 819M 143M Dec/2025
General Electric Aerospace USD 1.13B 47M Jun/2026
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 297.77M 20.7M Mar/2026
GN Store Nord DKK 763M 688M Mar/2026
Hitachi JPY 515.39B 55.69B Jun/2026
Idexx Laboratories USD 288.09M 11.76M Jun/2026
Insulet USD 317.2M 14.2M Mar/2026
Integra LifeSciences USD 166.22M 12.01M Jun/2026
Intuitive Surgical USD 617.9M 4.6M Jun/2026
J&J USD 6.42B 381M Jun/2026
Koninklijke Philips EUR 1.18B 335.05M Mar/2026
Medtronic 2.96B 9M Dec/2025
Philips EUR 1.21B 23M Jun/2026
ResMed USD 279.8M 1.4M Mar/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Steris USD 351.8M 500K Mar/2026
Stryker USD 2.12B 32M Jun/2026
Teleflex USD 226.01M 3.64M Mar/2026
Terumo JPY 114.81B 9.55B Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026